MENU
+Compare
SNPHF
Stock ticker: OTC
AS OF
Dec 9 closing price
Price
$10.53
Change
-$0.62 (-5.56%)
Capitalization
3.26B

SNPHF Santen Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SNPHF with price predictions
Dec 24, 2024

SNPHF's RSI Oscillator climbs out of oversold territory

The RSI Indicator for SNPHF moved out of oversold territory on December 03, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on December 23, 2024. You may want to consider a long position or call options on SNPHF as a result. In of 62 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SNPHF just turned positive on December 04, 2024. Looking at past instances where SNPHF's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for SNPHF crossed bearishly below the 50-day moving average on November 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.511) is normal, around the industry mean (5.632). P/E Ratio (15.314) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.027) settles around the average of (0.164) among similar stocks. P/S Ratio (1.667) is also within normal values, averaging (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SNPHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNPHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

View a ticker or compare two or three
SNPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published Dividends

SNPHF paid dividends on November 30, 2020

Santen Pharmaceutical Co., Ltd. SNPHF Stock Dividends
А dividend of $14.00 per share was paid with a record date of November 30, 2020, and an ex-dividend date of September 29, 2020. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IHSAX20.490.19
+0.94%
Hartford Small Company A
CZMSX16.600.15
+0.91%
Multi-Manager Small Cap Eq Strat Inst
MDISX28.780.11
+0.38%
Franklin Mutual Global Discovery Z
MFQAX17.15N/A
N/A
AMG Veritas Global Focus N
SSMOX11.12N/A
N/A
Steward Values Enhanced SmMidCapR6

SNPHF and Stocks

Correlation & Price change

A.I.dvisor tells us that SNPHF and RHHVF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHF and RHHVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHF
1D Price
Change %
SNPHF100%
N/A
RHHVF - SNPHF
7%
Poorly correlated
+0.22%
PTKFY - SNPHF
6%
Poorly correlated
N/A
PTKFF - SNPHF
2%
Poorly correlated
N/A
RHHBY - SNPHF
2%
Poorly correlated
+0.20%
SNPHY - SNPHF
1%
Poorly correlated
+12.91%
More